Two groups of subjects with obstructive lung disease, defined by pulmonary vascular reactivity.
D000628:Aminophylline / Q000494:pharmacology; D001991:Bronchitis / Q000503:physiopathology*; D002245:Carbon Dioxide / Q000097:blood; D006801:Humans; D010100:Oxygen / Q000097:blood / Q000494:pharmacology; D010313:Partial Pressure; D011652:Pulmonary Circulation; D011656:Pulmonary Emphysema / Q000503:physiopathology*; D012119:Respiration / Q000187:drug effects; D012129:Respiratory Function Tests; D013147:Spirometry; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000494:pharmacology
D014665:Vasodilator Agents; D002245:Carbon Dioxide; D000628:Aminophylline; D010100:Oxygen